CORE LIST

Complementary List

Route of Administration Pharmaceutical Forms and Strengths

Beta-adrenoceptor blockers ATENOLOL (B) (cardioselective/no ISA) METOPROLOL (B) (cardioselective/no ISA) PROPRANOLOL (B) (non-cardioselective/no ISA) Oral: 50 mg and 100 mg tablet

Oral: 50 mg and 100 mg tablet (as tartrate) Oral: 10 mg and 40 mg tablet (as hydrochloride) 40 mg CR capsule (as hydrochloride)

Angiotensin-converting enzyme (ACE) inhibitors CAPTOPRIL ENALAPRIL Oral: 25 mg and 50 mg tablet Oral: 5 mg, 10 mg and 20 mg tablet (as maleate)

Angiotensin-2-receptor blockers (ARBs) irbesartan losartan Oral: 75 mg, 150 mg and 300 mg tablet Oral: 50 mg and 100 mg tablet ( p ) (as potassium salt) Oral: 40 mg and 80 mg tablet Oral: 80 mg and 160 mg tablet/film coated tablet

telmisartan valsartan

5.1.5

Antiarrhythmic agents Ventricular AMIODARONE (2) Oral: 200 mg tablet (as hydrochloride) Inj.: 50 mg/mL, 3 mL ampul (IV) (as hydrochloride) Inj.: 20 mg/mL, 5 mL ampul/vial (IM, IV) (as hydrochloride) 100 mg/mL, 5 mL ampul (IV Infusion) (as hydrochloride) 4 mg/mL, 250 mL D5W (pre-mixed) (IV) (as hydrochloride) 250 mg/mL, 2 mL and 10 mL ampul (IV) (as heptahydrate) 250 mg/mL, 20 mL and 50 mL vial (IV) (as heptahydrate) 500 mg/mL, 2 mL and 10 mL ampul (IV) (as heptahydrate)

LIDOCAINE

(1, 2)

magnesium sulfate (1, 2)

Inj.:

PNDF Vol. I, 7th ed. (2008)

- 35 -

CORE LIST

Complementary List

Route of Administration Pharmaceutical Forms and Strengths Oral: 50 mg and 100 mg tablet (as tartrate) 10 mg and 40 mg tablet (as hydrochloride)

METOPROLOL (B) (cardioselective/no ISA) PROPRANOLOL (B) (non-cardioselective/no ISA)

Oral:

Centrally acting antihypertensives (alpha-2 adrenoceptor agonists) clonidine Oral: Inj.: 75 micrograms and 150 micrograms tablet (as hydrochloride) 150 micrograms/mL, 1 mL ampul (IV) (as hydrochloride) 125 mg and 250 mg tablet

methyldopa 5.2.3 Direct vasodilators GLYCERYL TRINITRATE (nitroglycerin) (1)

Oral:

Inj.:

1 mg/mL, 5 mL, 10 mL and 25 mL ampul (IV) 1 mg/mL, 50 mL vial (IV infusion) (especially for unstable angina) 10 mg, 25 mg and 50 mg t bl t d tablet (as hydrochloride) 20 mg/mL, 1 mL ampul (IM, IV) (as hydrochloride) 50 mg powder ampul (IV infusion)

HYDRALAZINE

Oral: O l Inj.:

SODIUM NITROPRUSSIDE 5.2.4 Calcium channel blockers NIFEDIPINE (B) amlodipine

(1, 2)

Inj.:

Oral: Oral:

20 mg and 30 mg SR tablet 5 mg and 10 mg tablet (as besilate/ camsylate) 2.5 mg, 5 mg and 10 mg ER tablet 10 mg and 20 mg tablet (as hydrochloride) 1 mg/mL, 2 mL and 10 mL ampul (IV) (as hydrochloride) (1) 5 mg and 10 mg capsule (restricted use for acute hypertensive emergencies in patients less than 18 years old with extreme caution due to rapid and prolonged fall in blood pressure)

felodipine nicardipine

(B)

Oral: Oral: Inj.:

nifedipine

(B)

Oral:

PNDF Vol. I, 7th ed. (2008)

- 38 -

CORE LIST

Complementary List

Route of Administration Pharmaceutical Forms and Strengths Oral: 30 mg tablet Inj.: 200 micrograms/mL, 50 mL (IV Infusion) 10 mg solution, 50 mL vial (IV Infusion) (1, 2)

nimodipine

5.2.5

Angiotensin-converting enzyme (ACE) inhibitors CAPTOPRIL ENALAPRIL Oral: 25 mg and 50 mg tablet Oral: 5 mg, 10 mg and 20 mg tablet (as maleate)

5.2.6

Angiotensin-2-receptor blockers (ARBs) candesartan eprosartan irbesartan losartan Oral: 8 mg and 16 mg tablet (as cilexetil) Oral: 600 mg tablet (as mesilate) Oral: 75 mg, 150 mg and 300 mg tablet Oral: 50 mg and 100 mg tablet (as potassium salt) Oral: 40 mg and 80 mg tablet g g Oral: 80 mg and 160 mg tablet/film coated tablet

telmisartan valsartan

Fixed-dose combinations enalapril + hydrochlorothiazide irbesartan + hydrochlorothiazide Oral: 20 mg enalapril (as maleate) + 12.5 hydrochlorothiazide tablet Oral: 150 mg irbesartan + 12.5 mg hydrochlorothiazide tablet 300 mg irbesartan + 12.5 mg hydrochlorothiazide tablet Oral: 50 mg losartan (as potassium salt) + 12.5 mg hydrochlorothiazide tablet 100 mg losartan (as potassium salt) + 25 mg hydrochlorothiazide tablet Oral: 40 mg telmisartan + 12.5 mg hydrochlorothiazide tablet 80 mg telmisartan + 12.5 mg hydrochlorothiazide tablet

losartan + hydrochlorothiazide

telmisartan + hydrochlorothiazide

PNDF Vol. I, 7th ed. (2008)

- 39 -